CELLECT Trademark

Trademark Overview

On Thursday, December 8, 2022, a trademark application was filed for CELLECT with the United States Patent and Trademark Office. The USPTO has given the CELLECT trademark a serial number of 97709666. The federal status of this trademark filing is SUBSEQUENT FINAL MAILED as of Tuesday, December 9, 2025. This trademark is owned by HiFiBiO Inc.. The CELLECT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
cellect

General Information

Serial Number97709666
Word MarkCELLECT
Filing DateThursday, December 8, 2022
Status660 - SUBSEQUENT FINAL MAILED
Status DateTuesday, December 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHiFiBiO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, December 12, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Thursday, October 5, 2023NON-FINAL ACTION WRITTEN
Thursday, October 5, 2023NON-FINAL ACTION E-MAILED
Thursday, October 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 16, 2024FINAL REFUSAL WRITTEN
Tuesday, January 16, 2024FINAL REFUSAL E-MAILED
Tuesday, January 16, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, March 26, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, March 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 7, 2024NON-FINAL ACTION WRITTEN
Monday, October 7, 2024NON-FINAL ACTION E-MAILED
Monday, October 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 9, 2025SUBSEQUENT FINAL REFUSAL WRITTEN
Tuesday, December 9, 2025SUBSEQUENT FINAL EMAILED
Tuesday, December 9, 2025NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Related Keywords

cellect fields biotechnology pharmaceutical development research